(Q83769670)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459722%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Expression of HLA-G in patients with hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459722%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

main subject

hepatocellular carcinoma

1 reference

Yan Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459722%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Zhou Ye

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459722%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Xue-Qin Meng

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459722%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Shu-Sen Zheng

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459722%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

1 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459722%20AND%20SRC:MED&resulttype=core&format=json

Hepatobiliary & Pancreatic Diseases International

27 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459722%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459722%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459722%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

158-163

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459722%20AND%20SRC:MED&resulttype=core&format=json

Cancer burden in the year 2000. The global picture

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

HLA-G molecules: from maternal-fetal tolerance to tissue acceptance

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

Expression of HLA-G in human cornea, an immune-privileged tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

The biological differences between ovarian serous carcinoma and diffuse peritoneal malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

Secretion of sHLA-G molecules in malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

Soluble HLA-G molecules are increased in lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

HLA-G suppresses proliferation of CD4(+) T-lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

Tolerization of dendritic cells by HLA-G.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

HLA-G and MIC expression in tumors and their role in anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960025-8

7 January 2021

10.1016/S1499-3872(11)60025-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459722%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference